QIPT vs. CPH, OGI, VHI, DR, CRDL, HLS, SVA, KSI, EDT, and MDNA
Should you be buying Quipt Home Medical stock or one of its competitors? The main competitors of Quipt Home Medical include Cipher Pharmaceuticals (CPH), Organigram (OGI), Vitalhub (VHI), Medical Facilities (DR), Cardiol Therapeutics (CRDL), HLS Therapeutics (HLS), Sernova (SVA), kneat.com (KSI), Spectral Medical (EDT), and Medicenna Therapeutics (MDNA). These companies are all part of the "medical" sector.
Quipt Home Medical (TSE:QIPT) and Cipher Pharmaceuticals (TSE:CPH) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, community ranking, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and profitability.
Cipher Pharmaceuticals received 166 more outperform votes than Quipt Home Medical when rated by MarketBeat users. However, 80.00% of users gave Quipt Home Medical an outperform vote while only 62.68% of users gave Cipher Pharmaceuticals an outperform vote.
Quipt Home Medical has a beta of 1.04, meaning that its stock price is 4% more volatile than the S&P 500. Comparatively, Cipher Pharmaceuticals has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500.
Cipher Pharmaceuticals has a net margin of 96.32% compared to Quipt Home Medical's net margin of -1.57%. Cipher Pharmaceuticals' return on equity of 28.19% beat Quipt Home Medical's return on equity.
In the previous week, Cipher Pharmaceuticals had 2 more articles in the media than Quipt Home Medical. MarketBeat recorded 2 mentions for Cipher Pharmaceuticals and 0 mentions for Quipt Home Medical. Quipt Home Medical's average media sentiment score of 0.00 equaled Cipher Pharmaceuticals'average media sentiment score.
45.7% of Quipt Home Medical shares are held by institutional investors. Comparatively, 1.0% of Cipher Pharmaceuticals shares are held by institutional investors. 3.9% of Quipt Home Medical shares are held by insiders. Comparatively, 44.7% of Cipher Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Cipher Pharmaceuticals has lower revenue, but higher earnings than Quipt Home Medical. Quipt Home Medical is trading at a lower price-to-earnings ratio than Cipher Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.
Quipt Home Medical presently has a consensus price target of C$11.74, suggesting a potential upside of 115.81%. Cipher Pharmaceuticals has a consensus price target of C$8.00, suggesting a potential downside of 7.83%. Given Quipt Home Medical's stronger consensus rating and higher possible upside, equities analysts clearly believe Quipt Home Medical is more favorable than Cipher Pharmaceuticals.
Summary
Cipher Pharmaceuticals beats Quipt Home Medical on 11 of the 18 factors compared between the two stocks.
Get Quipt Home Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for QIPT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding QIPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Quipt Home Medical Competitors List
Related Companies and Tools
